D. Boral Capital Reiterates Buy Rating for FibroBiologics (NASDAQ:FBLG)
FibroBiologics (NASDAQ:FBLG – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at D. Boral Capital in a research note issued on Tuesday,Benzinga reports. They presently have a $16.00 price target on the stock. Separately, HC Wainwright reaffirmed a “buy” rating and issued a $12.00 price objective on shares of FibroBiologics in […]
FibroBiologics (NASDAQ:FBLG – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at D. Boral Capital in a research note issued on Tuesday,Benzinga reports. They presently have a $16.00 price target on the stock. Separately, HC Wainwright reaffirmed a “buy” rating and issued a $12.00 price objective on shares of FibroBiologics in […]
